US FDA Getting Faster At Notifying Drug Facility Owners Of Inspection Status
Executive Summary
Agency issued final classification determinations within 90 days after an inspection 86% of the time in fiscal year 2019 and continues to reduce the time interval for sending GMP warning letters, CDER compliance director Donald Ashley tells FDLI conference.
You may also be interested in...
US FDA Facility Compliance Actions Could Accelerate Despite Inspections Freeze
No longer in the field, inspectors have more time to wrap up work on previously completed facility evaluations, attorney Howard Sklamberg says. The inspections freeze could delay manufacturers’ abilities to bring facilities into compliance following adverse inspection findings, as well as agency reclassifications of facility status.
US FDA Facility Compliance Actions Could Speed Up Despite Inspections Freeze
With inspectors no longer out in the field, they have more time to wrap up work on previously completed facility evaluations, attorney Howard Sklamberg says; inspections freeze could delay manufacturers’ abilities to bring facilities into compliance following adverse inspection findings, as well as agency reclassifications of facility status.
First-Ever OTC Inspections Drove Surge Of FDA Warning Letters In FY 2019
The good news: 75% of never-before-inspected firms complied with US drug GMP requirements. The bad news: 25% did not.